PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Droplet Digital PCR enables measurement of potential cancer survival biomarker

2013-12-05
(Press-News.org) Contact information: Ken Li
kli@chempetitive.com
312-532-4675
Chempetitive Group
Droplet Digital PCR enables measurement of potential cancer survival biomarker Seattle, WA – December 4, 2013 – Researchers at Fred Hutchinson Cancer Research Center have used Droplet Digital PCR (ddPCR™) to demonstrate for the first time the quantification of a special class of tumor-attacking immune cell known to improve cancer survival, a subpopulation of T-cells called tumor-infiltrating T-lymphocytes or TILs. The study, led by Dr. Jason Bielas, Associate Member of the Public Health Sciences Division at Fred Hutch, paves the way for further study of the role of TIL quantification in immunotherapy and as a cancer survival predictor.

"Now that we have the sensitivity and ability to reproducibly count TILs in tumors, we may be able to stratify and more effectively treat patients based on tumor TIL count, especially with immunotherapeutics coming to market," said Dr. Bielas, one of the lead authors of a paper reporting the TIL quantification results in Science Translational Medicine.

Quantifying TILs Using ddPCR TILs directly attack tumor cells in a variety of cancer types. While the presence and quantity of TILs strongly correlate with increased patient survival, current tests are semiquantitative at best. As a result, TILs cannot be used for clinical decision making.

According to Dr. Bielas, TILs have a "genomic signature that can be digitally exploited." This signature, which exhibits a vast amount of diversity, determines the genetic identity, or clonality, of the T-cell receptors (TCR) expressed on the surface of each TIL. With the advent of digital PCR – and the generation of tens of thousands of data points produced by Droplet Digital PCR – it is now possible to quantify these signatures, enabling the determination of the number of TILs.

"There's no way you could do this with any method other than digital PCR because of the numerous primer pairs and probes that we have (45 forward primers, 13 reverse primers, and 30 probes)," said Dr. Bielas. "Digital PCR partitions all the reactions so you can amplify these targets independently of PCR efficiency without any competing side reactions."

Fred Hutch researchers developed the Droplet Digital PCR-based "QuanTILfy" assay using Bio-Rad Laboratories' QX100 ddPCR system. They then used QuanTILfy to count TILs, determine their frequency, and develop a grouping system to classify "clonality," which might be a marker of druggable targets.

Study Results Fred Hutch researchers performed the QuanTILfy assay on primary tumors from 30 ovarian carcinoma patients with known survival outcomes, ranging from 1 to 122 months. TIL frequency was approximately threefold higher in patients with a survival rate of more than five years compared with patients with survival rates of less than two years. These results show that higher TIL levels correlate positively with patient survival, consistent with the hypothesis that TILs play an active role in suppressing tumor formation.

The researchers also demonstrated that QuanTILfy can be used to accurately and reproducibly characterize T-cell clonality in patients with T-cell acute lymphoblastic leukemia. In each case, they saw a single QuanTILfy assay subgroup, indicative of clonal T-cell expansion. This finding was confirmed by deep sequencing.

The QuanTILfy assay proved to be both sensitive and accurate. In a mixture of human T-cells purified from blood and normal human lung fibroblasts, the assay demonstrated the ability to detect a single TCR rearrangement among 10,000 tumor cells. Importantly, it also demonstrated the ability of ddPCR technology to quantify a large number of markers simultaneously in a single reaction through multiplexing.

### The authors acknowledge support from the Listwin Family Foundation (to J.H.B.), an Ellison Medical Foundation New Scholar award (AG-NS-0577-09, to J.H.B), an Outstanding New Environmental Scientist Award (ONES) (R01) from the National Institute of Environmental Health Sciences (R01ES019319, to J.H.B.), a grant from the Congressionally Directed Medical Research Programs/U.S. Department of Defense (W81XWH-10-1-0563, to J.H.B.), the Pacific Ovarian Cancer Research Consortium Ovarian Cancer SPORE Award (P50 CA083636), a Department of Defense Ovarian Cancer Idea Award (OC093221, to M.T.), a Susan G. Komen postdoctoral fellowship (to J.G.), and from the Canary Foundation (to M.T.).

About Fred Hutchinson Cancer Research Center At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose, and treat cancer, HIV/AIDS, and other life-threatening diseases. Fred Hutch's pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation's first and largest cancer prevention research program, as well as the clinical coordination center of the Women's Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential in enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information, visit http://www.fredhutch.org or follow Fred Hutch on Facebook, Twitter, or YouTube.

About Bio-Rad Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has been at the center of scientific discovery for 60 years, manufacturing and distributing a broad range of products for life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and industry customers through its global network of operations. The company employs approximately 7,300 people worldwide and had revenues exceeding $2 billion in 2012. Visit us at http://www.bio rad.com.


ELSE PRESS RELEASES FROM THIS DATE:

How our nerves keep firing

2013-12-05
How our nerves keep firing Biologists see ultrafast recycling of neurotransmitter-filled bubbles SALT LAKE CITY, Dec. 4, 2013 –University of Utah and German biologists discovered how nerve cells recycle tiny bubbles or "vesicles" that send chemical nerve signals from ...

Youthful suicide attempts a marker for lifelong troubles

2013-12-05
Youthful suicide attempts a marker for lifelong troubles Difficult to predict, but once it happens, key clue for long-term needs DURHAM, N.C. -- A study that tracked more than 1,000 New Zealanders from birth to age 38 has found that those who attempted suicide before age ...

Study reveals impact of time differences on international trade

2013-12-05
Study reveals impact of time differences on international trade International time differences have a negative and economically significant impact on trade between countries, according to research published this week. The study by Dr Edward Anderson, of the ...

Oldest hominin DNA sequenced

2013-12-05
Oldest hominin DNA sequenced This news release is available in German. Using novel techniques to extract and study ancient DNA researchers at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, have determined an almost complete ...

Telemedicine brings Parkinson's care to 'anyone, anywhere'

2013-12-05
Telemedicine brings Parkinson's care to 'anyone, anywhere' A new study shows that a neurologist in an office thousands of miles away can deliver effective specialized care to people with Parkinson's disease. For individuals with the condition ...

What a Formula 1 race does to your eardrums

2013-12-05
What a Formula 1 race does to your eardrums Track-side noise may exceed 8,500 percent of a person's daily recommended noise exposure, according to new research presented at the 166th meeting of the Acoustical Society of America SAN FRANCISCO, Dec. 2, 2013 – ...

'Valley Girl' dialect expanding to males

2013-12-05
'Valley Girl' dialect expanding to males Uptalk is on the uptick, says new linguistics study SAN FRANCISCO, Dec. 2, 2013 – The American English speech variant known as uptalk, or "Valley Girl speak" – marked by a rise in pitch at the ends of sentences – is typically ...

University of Maryland scientists develop new understanding of chlamydial disease

2013-12-05
University of Maryland scientists develop new understanding of chlamydial disease Novel simultaneous RNA-Seq analysis tracks host/pathogen interactions Baltimore, Md. — December 4, 2013. Investigators at the Institute for Genome Sciences at the University ...

Tripped tongues teach speech secrets

2013-12-05
Tripped tongues teach speech secrets Say that 10 times fast, then read on: MIT researchers discuss what tongue twister-induced speech errors may tell us about our brains at a meeting of the Acoustical Society of America in San Francisco SAN FRANCISCO, Dec. 2, ...

Predicting ovarian cancer survival through tumor-attacking immune cells

2013-12-05
Predicting ovarian cancer survival through tumor-attacking immune cells SEATTLE – One way to predict survival of many types of cancer is by counting the number of tumor-attacking immune cells that have migrated into the tumor in an effort to eradicate ...

LAST 30 PRESS RELEASES:

Mysterious ‘Dark Dwarfs’ may be hiding at the heart of the Milky Way

Real-world data shows teclistamab can benefit many multiple myeloma patients who would have been ineligible for pivotal trial

Scientists reveal how a key inflammatory molecule triggers esophageal muscle contraction

Duration of heat waves accelerating faster than global warming

New mathematical insights into Lagrangian turbulence

Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug

Artificial solar eclipses in space could shed light on Sun

Probing the cosmic Dark Ages from the far side of the Moon

UK hopes to bolster space weather forecasts with Europe's first solar storm monitor

Can one video change a teen's mindset? New study says yes - but there’s a catch

How lakes connect to groundwater critical for resilience to climate change, research finds

Youngest basaltic lunar meteorite fills nearly one billion-year gap in Moon’s volcanic history

Cal Poly Chemistry professor among three U.S. faculty to be honored for contributions to chemistry instruction

Stoichiometric crystal shows promise in quantum memory

Study sheds light on why some prostate tumors are resistant to treatment

Tree pollen reveals 150,000 years of monsoon history—and a warning for Australia’s northern rainfall

Best skin care ingredients revealed in thorough, national review

MicroRNA is awarded an Impact Factor Ranking for 2024

From COVID to cancer, new at-home test spots disease with startling accuracy

Now accepting submissions: Special Collection on Cognitive Aging

Young adult literature is not as young as it used to be

Can ChatGPT actually “see” red? New results of Google-funded study are nuanced

Turning quantum bottlenecks into breakthroughs

Cancer-fighting herpes virus shown to be an effective treatment for some advanced melanoma

Eliminating invasive rats may restore the flow of nutrients across food chain networks in Seychelles

World’s first: Lithuanian scientists’ discovery may transform OLED technology and explosives detection

Rice researchers develop superstrong, eco-friendly materials from bacteria

Itani studying translation potential of secure & efficient software updates in industrial internet of things architectures

Elucidating the source process of the 2021 south sandwich islands tsunami earthquake

Zhu studying use of big data in verification of route choice models

[Press-News.org] Droplet Digital PCR enables measurement of potential cancer survival biomarker